[Federal Register Volume 65, Number 186 (Monday, September 25, 2000)]
[Notices]
[Page 57621]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-24560]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE


Drug Enforcement Administration Manufacturer of Controlled 
Substances; Notice of Application

    Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on July 24, 2000, American 
Radiolabeled Chemical, Inc., 11624 Bowling Green Drive, St. Louis, 
Missouri 63146, made application by renewal to the Drug Enforcement 
Administration (DEA) for registratin as a bulk manufacturer of the 
basic classes of controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Gamma hydroxybutyric acid (2010)...........  I
Lysergic acid diethylamide (7315)..........  I
Dimethyltryptamine (7435)..................  I
Dihydromorphine (9145).....................  I
Phencyclidine (7471).......................  II
Cocaine (9041).............................  II
Codeine (9050).............................  II
Hydromorphone (9150).......................  II
Benzoylecgonine (9180).....................  II
Meperidine (9230)..........................  II
Metazocine (9240)..........................  II
Morphine (9300)............................  II
Oxymorphone (9652).........................  II
------------------------------------------------------------------------

    The firm plans to bulk manufacture small quantities of the listed 
controlled substances as radiolabeled compound.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than November 24, 2000.

    Dated: September 6, 2000.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control Drug 
Enforcement Administration.
[FR Doc. 00-24560 Filed 9-22-00; 8:45 am]
BILLING CODE 4410-09-M